36
Participants
Start Date
January 24, 2019
Primary Completion Date
January 27, 2020
Study Completion Date
January 27, 2020
12-day intervention with sensor-augmented pump therapy
"A sensor will be inserted on the day before the start of the intervention by the participants. The participant will also have to install the study insulin pump. Participants will be advised to continue with study intervention at home for the next 12 days.~Participants will have been previously shown how to use the study insulin pump."
12-day intervention with single-hormone closed-loop strategy
"A sensor will be inserted on the day before the start of the intervention by the participants. On the first day of the intervention, participants will be admitted to the clinical research facility anytime between 8:00 am and 11:30 am. Training on connection and disconnection of the system, meal boluses, etc. will be given.~Only participants demonstrating competency on use of study devices will be allowed to continue to the home study phase. Participants will be advised to continue with study intervention at home for the next 12 days."
Insulin pump
Tandem Diabetes Care
Continuous glucose monitoring system
Dexcom G5 Platinum
Insulin
Participant's usual fast-acting insulin analog will be used: Lispro (Humalog), Aspart (NovoRapid) or Glulisine (Apidra)
Institut de recherches cliniques de Montréal, Montreal
McGill University Health Centre, Montreal
Institut de Recherches Cliniques de Montreal
OTHER